Treatment of Childhood Acute Lymphoblastic Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen E. Sallan, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcmaster University
Hamilton, Ontario, Canada
- Laval University
Montreal, Quebec, Canada
- Sainte Justine Hosptial
Montreal, Quebec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Ochsner Clinic
New Orleans, Louisiana, United States
- Maine Medical Center
Lewiston, Maine, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mt. Sinai Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 1996
- Primary completion
- 30 Sept 2006
- Completion
- 30 Sept 2006
- Last update posted
- 28 Dec 2007
- Registered enrollment
- 491
- Registry id
- NCT00165087
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.